Aspirin (acetylsalicylic acid) is a non-steroidal anti-inflammatory drug (NSAID) and antiplatelet that is taken orally and commonly used for the treatment of pain. It is highly genericized and has been available in its present form since 1899, when it was first marketed by Bayer. Aspirin’s use as a possible ischemic stroke prevention medicine was first noted in the 1950s . For the treatment of ischemic stroke, antiplatelets are used to prevent thrombosis in atherosclerotic arteries to the brain.
LIST OF FIGURES
5 Figure 1: Datamonitor Healthcare’s drug assessment summary of Aspirin for ischemic stroke
6 Figure 2: Datamonitor Healthcare’s drug assessment summary of Aspirin for ischemic stroke
8 Figure 3: Aspirin sales for ischemic stroke across the US, Japan, and five major EU markets, by country, 2016–25
LIST OF TABLES
9 Table 1: Aspirin franchise sales for ischemic stroke across the US, Japan, and five major EU markets, by country ($m), 2016–25
This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.